Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d21cbff64022f95c237c0bd3ec8656ca |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2770-36171 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2770-36161 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2770-36134 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5254 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2840-203 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-86 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N7-045 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N7-00 |
filingDate |
2013-04-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_84b6b567687e6f15c1410ee63f09197d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1a2f808cb2a37629dd2600d6c6c838b9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f50ec25c0c65ff216c248189f072e5e7 |
publicationDate |
2014-01-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2014010841-A1 |
titleOfInvention |
Attenuated Recombinant Alphaviruses Incapable of Replicating in Mosquitoes and Uses Thereof |
abstract |
The present invention discloses an attenuated recombinant alphavirus that is incapable of replicating in mosquito cells and of transmission by mosquito vectors. These attenuated alphavirus may include but is not limited to Western Equine Encephalitis virus, Eastern equine encephalitis virus, Venezuelan equine encephalitis virus or Chikungunya virus. The present invention also discloses the method of generating such alphaviruses and their use as immunogenic compositions. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11591619-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11771747-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8961995-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11504421-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11510973-B2 |
priorityDate |
2008-01-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |